UK / 7 people who suffered blood clots after Oxford COVID-19 vaccine die in UK

Seven people who suffered blood clots after receiving the Oxford-AstraZeneca vaccine against coronavirus have died in the UK, the nation's medicines regulator has said. In total, 30 people out of 1.8 crore vaccinated in the UK by March 24 had these clots, it added. This comes amid decision by several European countries to pause the use of the AstraZeneca vaccine.

Vikrant Shekhawat : Apr 05, 2021, 11:32 AM
London: Out of the 30 cases of blood clots reported in the UK among the people who received jabs of the AstraZeneca-Oxford COVID-19 vaccine, 7 have died, informed the UK medical regulator. 

In a statement sent to news agency AFP, Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) said, “Out the 30 reports up to and including 24 March, sadly 7 have died.

Earlier, British regulators said that out of the more than 18 million AstraZeneca coronavirus vaccine doses administered in Britain, only around 30 cases of blood clots were reported. The new number of cases is 25 more than what was reported last month.

The UK medical regulator described the risk of blood clots associated with the vaccine as “very small”.

As of March 24, a total of 22 cases of cerebral vein thrombosis and eight other types of thrombosis had been reported, the agency said.

Another document from the authority listed a total of 24 cases of cerebral vein thrombosis, without providing details about the discrepancy.

“On the basis of this ongoing review, the benefits of the vaccines against Covid-19 continue to outweigh any risks and you should continue to get your vaccine when invited to do so,” the regulator said.

In total, more than 31 million people in Britain have received the first dose of the vaccination, more than 18 million of them with AstraZeneca.

The number of cases has improved significantly, with the seven-day incidence figure at 55 per 100,000 inhabitants.

Two Covid-19 vaccines, Pfizer/BioNTech and Oxford University/AstraZeneca, are currently being used in the UK.